Murray Stewart SEC EDGAR Filings (CIK 0001723450)

SEC EDGAR filings, ownership reports, and insider transactions for Murray Stewart.

Business address
C/O X4 Pharmaceuticals, Inc., 61 North Beacon St, 4 Th Floor, Boston, MA, 02134
Top holdings (ownership)
XFOR
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Murray Stewart has filed 23 SEC EDGAR filings since 29 Nov 2017

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 05 Jan 2026 01 Jan 2026 001-38295
4 Open Document Open Filing FORM 4 10 Jun 2025 09 Jun 2025 001-38295
4 Open Document Open Filing FORM 4 19 Mar 2025 17 Mar 2025 001-42365
3 Open Document Open Filing FORM 3 19 Mar 2025 17 Mar 2025 001-42365
4 Open Document Open Filing FORM 4 11 Jun 2024 10 Jun 2024 001-38295
4 Open Document Open Filing FORM 4 11 Aug 2023 09 Aug 2023 001-38295
4 Open Document Open Filing PRIMARY DOCUMENT 12 Jan 2023 09 Jan 2023 000-21392
3 Open Document Open Filing PRIMARY DOCUMENT 12 Jan 2023 09 Jan 2023 000-21392
4 Open Document Open Filing FORM 4 27 Jun 2022 06 Jun 2022 001-38295
4 Open Document Open Filing FORM 4 02 Jun 2021 02 Jun 2021 001-38295
4 Open Document Open Filing OWNERSHIP DOCUMENT 16 Feb 2021 11 Feb 2021 001-38223
4 Open Document Open Filing FORM 4 21 Oct 2020 20 Oct 2020 001-38295
4 Open Document Open Filing 4 02 Jul 2020 30 Jun 2020 001-38223
4 Open Document Open Filing FORM 4 11 Jun 2020 10 Jun 2020 001-38295
4 Open Document Open Filing 4 19 Feb 2020 14 Feb 2020 001-38223
4 Open Document Open Filing FORM 4 SUBMISSION 02 Apr 2019 29 Mar 2019 001-38295
3 Open Document Open Filing FORM 3 SUBMISSION 02 Apr 2019 29 Mar 2019 001-38295
4 Open Document Open Filing 4 15 Feb 2019 13 Feb 2019 001-38223
4 Open Document Open Filing 4 17 Oct 2018 15 Oct 2018 001-38223
3 Open Document Open Filing 3 17 Oct 2018 15 Oct 2018 001-38223
4 Open Document Open Filing 4 14 Feb 2018 12 Feb 2018 000-17082
4 Open Document Open Filing 4 29 Nov 2017 27 Nov 2017 000-17082
3 Open Document Open Filing 3 29 Nov 2017 27 Nov 2017 000-17082